Several clinical studies have reported elevated serum levels of TIMP-1 in patients of colorectal cancer and lung cancer, suggesting TIMP-1 as a useful serum biomarker for the diagnosis and prognosis of cancers and inflammatory disorders (36, 37, 38). Here, TIMP1 is linked to lung carcinoma.